Literature DB >> 23592020

Positive association between Toll-like receptor 4 gene +896A/G polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis.

Tian-Hui Zou1, Zhen-Hua Wang, Jing-Yuan Fang.   

Abstract

Several studies have investigated the association between the Toll-like receptor 4 (TLR4) gene +896A/G polymorphism and gastric carcinogenesis, including gastric cancer and precancerous gastric lesions. However, published results are inconsistent. So, we performed a meta-analysis to assess whether the TLR4 +896A/G single-nucleotide polymorphism (SNP) is a risk factor in gastric cancer development. We searched PubMed and Embase databases for studies that reported the odds ratio (OR) and 95 % confidence interval (CI) for the association between the TLR4 +896A/G SNP and the risk of gastric cancer and/or precancerous lesions with the last update of November 2012. Data were analyzed using Review Manager (Version 5.1), and publication bias was estimated. We included 10 study populations, comprising 2,233 cases and 2,849 controls from 8 publications. The pooled OR was 2.00 (95 % CI = 1.59-2.53) for the G allelic model. Analysis stratified by different stages and anatomic sites of neoplasia resulted in a significantly increased risk associated with gastric cancer (OR = 1.87, 95 % CI = 1.44-2.44), especially the non-cardia subtype (OR = 2.03, 95 % CI = 1.51-2.72). Besides, the G allele emerged as a strong risk factor for precancerous gastric lesions (OR = 2.47, 95 % CI = 1.57-3.88). A subsequent subgroup analysis by Helicobacter pylori-positive ratio in cases (>80 %) indicated an enhancement in the association with precancerous lesions (OR = 3.43, 95 % CI = 1.92-6.13). The TLR4 +896A/G SNP is a risk factor in gastric carcinogenesis, especially in H. pylori-infected patients with precancerous lesions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23592020     DOI: 10.1007/s13277-013-0795-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  39 in total

1.  TLR4 gene variants modify endotoxin effects on asthma.

Authors:  Monika Werner; Rebekka Topp; Katrin Wimmer; Kai Richter; Wolfgang Bischof; Matthias Wjst; Joachim Heinrich
Journal:  J Allergy Clin Immunol       Date:  2003-08       Impact factor: 10.793

2.  TLR4 and NOD2/CARD15 genetic polymorphisms and their possible role in gastric carcinogenesis.

Authors:  L Rigoli; C Di Bella; F Fedele; V Procopio; M Amorini; G Lo Giudice; P Romeo; F Pugliatti; G Finocchiaro; R Lucianò; R A Caruso
Journal:  Anticancer Res       Date:  2010-02       Impact factor: 2.480

3.  A method for meta-analysis of molecular association studies.

Authors:  Ammarin Thakkinstian; Patrick McElduff; Catherine D'Este; David Duffy; John Attia
Journal:  Stat Med       Date:  2005-05-15       Impact factor: 2.373

4.  Interleukin 10 polymorphisms differentially influence the risk of gastric cancer in East Asians and Caucasians.

Authors:  Hong-Hee Won; Jong-Won Kim; Min-Ji Kim; Seonwoo Kim; Jun-Hee Park; Kyung-A Lee
Journal:  Cytokine       Date:  2010-04-02       Impact factor: 3.861

5.  Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach.

Authors:  Hiroaki Saito; Youji Fukumoto; Tomohiro Osaki; Kenji Fukuda; Shigeru Tatebe; Shunichi Tsujitani; Masahide Ikeguchi
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

6.  Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes.

Authors:  D Santini; S Angeletti; A Ruzzo; G Dicuonzo; S Galluzzo; B Vincenzi; A Calvieri; F Pizzagalli; N Graziano; E Ferraro; G Lorino; A Altomare; M Magnani; F Graziano; G Tonini
Journal:  Clin Exp Immunol       Date:  2008-09-29       Impact factor: 4.330

7.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Authors:  Benjamin Chun-Yu Wong; Shiu Kum Lam; Wai Man Wong; Jian Shun Chen; Ting Ting Zheng; Rui E Feng; Kam Chuen Lai; Wayne Hsing Cheng Hu; Siu Tsan Yuen; Suet Yi Leung; Daniel Yee Tak Fong; Joanna Ho; Chi Kong Ching; Jun Shi Chen
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

8.  Association of polymorphism of TLR4 and CD14 genes with gastroduodenal diseases in Japan.

Authors:  T Tahara; T Arisawa; T Shibata; I Hirata; H Nakano
Journal:  Inflammopharmacology       Date:  2007-06       Impact factor: 4.473

9.  TLR4 single-nucleotide polymorphisms alter mucosal cytokine and chemokine patterns in Mexican patients with Helicobacter pylori-associated gastroduodenal diseases.

Authors:  Alejandra Trejo-de la O; Javier Torres; Martha Pérez-Rodríguez; Margarita Camorlinga-Ponce; L Flores Luna; José M Abdo-Francis; Eduardo Lazcano; Carmen Maldonado-Bernal
Journal:  Clin Immunol       Date:  2008-08-27       Impact factor: 3.969

10.  Polymorphisms in genes related to bacterial lipopolysaccharide/peptidoglycan signaling and gastric precancerous lesions in a population at high risk for gastric cancer.

Authors:  Ikuko Kato; Federico Canzian; Martyn Plummer; Silvia Franceschi; Leen-Jan van Doorn; Jorge Vivas; Gladys Lopez; Yanhui Lu; Lydie Gioia-Patricola; Richard K Severson; Ann G Schwartz; Nubia Muñoz
Journal:  Dig Dis Sci       Date:  2006-12-14       Impact factor: 3.487

View more
  9 in total

1.  N-acetyltransferase 2 status and gastric cancer risk: a meta-analysis.

Authors:  Jian Yu; Yue Deng; Jian-Ping Chen
Journal:  Tumour Biol       Date:  2014-04-15

2.  Factors affecting occurrence of gastric varioliform lesions: A case-control study.

Authors:  Tian-Hui Zou; Ru-Hua Zheng; Qin-Yan Gao; Xuan Kong; Xiao-Yu Chen; Zhi-Zheng Ge; Ying-Xuan Chen; Xiao-Ping Zou; Jing-Yuan Fang
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

Review 3.  Toll-like receptor-4 modulation for cancer immunotherapy.

Authors:  Shanjana Awasthi
Journal:  Front Immunol       Date:  2014-07-25       Impact factor: 7.561

4.  Association between TLR4 (+896A/G and +1196C/T) polymorphisms and gastric cancer risk: an updated meta-analysis.

Authors:  Quan Zhou; Chenchen Wang; Xiaofeng Wang; Xiongyan Wu; Zhenggang Zhu; Bingya Liu; Liping Su
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

5.  Clinicopathological Features and Increased Expression of Toll-Like Receptor 4 of Gastric Cardia Cancer in a High-Risk Chinese Population.

Authors:  Guangcan Chen; Muming Xu; Jingyao Chen; Liangli Hong; Wenting Lin; Shukun Zhao; Guohong Zhang; Guo Dan; Shuhui Liu
Journal:  J Immunol Res       Date:  2018-02-18       Impact factor: 4.818

Review 6.  Toll-like receptor 4 gene polymorphisms and susceptibility to colorectal cancer: a meta-analysis and review.

Authors:  Wang Yan Sheng; Zhang Yong; Zhu Yun; Hu Hong; Luo Lin Hai
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

Review 7.  Trial Watch: Toll-like receptor agonists for cancer therapy.

Authors:  Erika Vacchelli; Alexander Eggermont; Catherine Sautès-Fridman; Jérôme Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-06-10       Impact factor: 8.110

8.  Trial Watch: Toll-like receptor agonists in oncological indications.

Authors:  Fernando Aranda; Erika Vacchelli; Florine Obrist; Alexander Eggermont; Jérôme Galon; Catherine Sautès-Fridman; Isabelle Cremer; Jan Henrik Ter Meulen; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-08-01       Impact factor: 8.110

Review 9.  Pattern-recognition receptors and gastric cancer.

Authors:  Natalia Castaño-Rodríguez; Nadeem O Kaakoush; Hazel M Mitchell
Journal:  Front Immunol       Date:  2014-07-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.